Mymillions, you do make some valid points. At the moment it is talk and plans and this now needs to translate into actions. Like they say, the proof is in the pudding and we will have to see what transpires.
CGP is a speculative stock, I don't think anyone doubts that. I originally invested because I liked the assets - BA, vibrovein and linguet. They are now concentrating their efforts into getting BA to market and vibrovein is currently on the backburner until they see some revenue from BA. I believe there is a market for the BA, some variants more than others. I believe that we will see a licencing deal with big pharma 1H 2014. Everything management have said they will do they have done. I am much more comfortable now than 6 months ago when this company was a laughing stock. The focus has come back to the assets now, so it's up to management to take the necessary steps. With regard to current management, I've done my research and all I can say is teams get things done, individuals don't. Both MJ and MR have been involved in successful teams with successful products. Long termers have seen what certain individuals with power can do to a company. If our management perform and the company lives up to expectations they will also make money through their options.
I constantly re-assess my holdings, you'd be mad not to. However, cgp makes up part of my portfolio and I think the risk reward is there. If the milestones arn't achieved I'll reassess then. Might see you back here in 12 months time and we can both see where the company is at :)
Good luck :)
CGP Price at posting:
4.4¢ Sentiment: Buy Disclosure: Held
